Search for Clinical Trial Results

Sponsored By

Paramyotonia Congenita - 6 Studies Found

Status Study
Recruiting Study Name: Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
Condition:
  • Myotonia Congenita (Enrollment Complete)
  • Paramyotonia Congenita
    Date: 2014-09-25
    Interventions: Drug: Ranolazine Ranexa is FDA approved for chronic angina
Completed Study Name: Mexiletine and Non Dystrophic Myotonias
Condition:
  • Non-dystrophic Myotonias
  • Paramyotonia Congenita
  • Date: 2015-01-08
    Interventions:
    • Drug: Mexiletine

Completed Study Name: Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders
Condition:
  • Paralysis, Hyperkalemic Periodic
  • Hypokalemic Periodic Paralysis
  • Dystrophia Myotonica Type 1
  • Myotonia Congenita
  • Date: 2013-08-23
    Interventions:
    • Drug: Lamotrigine Other Name:

Completed Study Name: Characteristics of Nondystrophic Myotonias
Condition:
  • Nondystrophic Myotonias
  • Myotonia Congenita
  • Myotonic Disord
    Date: 2005-10-24
Completed Study Name: Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM)
Condition: Non Dystrophic Myotonia
Date: 2013-11-18
Interventions:
  • Drug: Mexiletine